OSL — Oncosil Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$18.62m
- AU$13.84m
- AU$0.43m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 4.49 | 3.91 | 2.99 | 0.842 | 0.884 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -7.5 | -4.46 | -8.82 | -10.1 | -11.3 |
Capital Expenditures | -0.015 | -0.021 | -0.054 | -0.006 | -0.058 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.015 | -0.021 | -0.054 | -0.006 | -0.058 |
Financing Cash Flow Items | 0 | -1.22 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 17.8 | 0.111 | 9.16 | 9.49 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7.52 | 13.3 | -8.76 | -0.96 | -1.89 |